“merck” Archives

in
Entry Author Date Location
FDA Landmark Nod: Cancer Drug To Match Tumor Genes, Not Tissue Type 05/23/17 National
Eli Lilly Migraine Drug Hits Study Goals, Paves Way for FDA Filing 05/12/17 Indiana
Bio Roundup: Big Apple Mo’, Checkpoint Yes and No, CAR-T Death & More 05/12/17 National
Merck Immunotherapy Drug Notches Another FDA Win in Lung Cancer 05/11/17 New York
With $75M Haul, Ovid Continues Flurry of Biotech IPOs 05/04/17 New York
Zymeworks Bags $58M in IPO to Bankroll Cancer Drug Trials 04/28/17 Seattle
Gates Foundation Leads $45.5M Round for Gerngross’s Biotech Arsanis 04/26/17 Boston
Phoenix Shops Its Cancer Drug as Potential Alzheimer’s Treatment 04/20/17 Texas
A.I. Startup Atomwise Has a Deal for Researchers Hunting for New Drugs 04/19/17 San Francisco
With Ovid IPO, Ex-Teva CEO Levin Pitches Neuro Drug Plan to Wall Street 04/11/17 New York
Emulate’s “Organ-on-a-Chip” Tech Picked for FDA Research Partnership 04/11/17 Boston
AACR Review: Biden Fired Up, Incyte Doubles Up, BMS Up And Down 04/06/17 National
Gedeon Richter Gets Ex-U.S. Rights for Evestra Urological Product 04/06/17 Texas
First Trial Underway, CytomX Gets $200M More In Expanded Bristol Pact 03/20/17 San Francisco
With New Data, Amgen Promises Refund If Cholesterol Drug Doesn’t Work 03/17/17 San Francisco
Bio Roundup: Trump Budget, FDA Chief, CAR-T Qs, CRISPR Cash, & More 03/17/17 National
Evestra Signs Deal with Glemark for Generic Version of NuvaRing 03/01/17 Texas
Drugmakers, Amazon Back Grail’s Big Cancer Trials With $900M 03/01/17 San Francisco
Former FDA Commissioners Califf, McClellan Talk Healthcare’s Future 03/01/17 National
At Arrakis, Gilman Teams With Biogen Vets to Target RNA With Pills 02/27/17 Boston
Bio Roundup: CRISPR Drama, Marathon and PhRMA, the Price of Vision & More 02/17/17 National
Merck Alzheimer Drug Is Latest To Fail In A Big Study 02/15/17 National
Polish Subsidiary of San Antonio Firm Gets $4.6M for Endometriosis 01/26/17 Texas
Notes From The JPM ’17 Vortex: Trump, Rainstorms & The Price You Pay 01/13/17 National
Manufacturing Issues Stall Tesaro Cancer Nausea Drug at FDA 01/12/17 Boston
Vertex Deals Cancer Drugs to Merck KGaA for $230M, Following Plan 01/11/17 Boston
At Allergan And Other Pharmas, Price Transparency Has Limits 01/11/17 National
Pain Drug Developer Adynxx Picks Up $16M for Another Clinical Trial 01/10/17 San Francisco
First Trial Underway, Jounce Preps IPO To Fund Immuno-Oncology Work 01/03/17 Boston
14 For ’17: Key Clinical Data to Watch For Next Year (Part 1) 12/21/16 National
Page 1 of 21 next page »